Top Markets
#1 TENDIES TENDIES +28.53%
#2 Songbird Songbird +15.60%
#3 MarsCoin MarsCoin +12.86%
#4 Pons Pons +12.14%
#5 DAPPOS DAPPOS +10.63%
#6 Cryptopia Cryptopia +9.23%
#7 Biconomy Biconomy +8.72%
#8 Lista DAO Lista DAO +8.12%
#9 Prom Prom +7.08%
#10 Magma Finance Magma Finance +6.83%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Rank in Stocks #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Share Price
$0.84484795
Last synced: 2026-08-28
Market Cap
$892.08M
Change (1 day)
-4.11%
Change (1 year)
27.37%
Country
CN
Trade Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Category

Healthcare
Revenue for Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
Revenue in Aug 2026 TTM: 0
According to Chongqing Lummy Pharmaceutical Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Chongqing Lummy Pharmaceutical Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US